Search for Clinical Trial Results

Sponsored By

Leukemia, T-cell, Chronic - 25 Studies Found

Status Study
Active, not recruiting Study Name: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Condition: Adult T-cell Leukemia-Lymphoma
Date: 2012-06-19
Interventions:
  • Biological: KW-0761 1.0 mg/kg

Completed Study Name: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma
Condition: Acute T-Cell Leukemia-Lymphoma
Date: 2003-05-20
Interventions: Biological: Alemtuzumab Infusion of Campath-1H 3 mg on day # 1, 10 mg on day #2, and 30 mg day # 3 follo
Active, not recruiting Study Name: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Condition: Adult T-Cell Leukemia (ATL)
Date: 2009-06-17
Interventions:
  • Drug: LMB-2 Begin with 30 mcg/
Completed Study Name: Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma
Condition: Adult T-cell Leukemia-lymphoma
Date: 2009-06-09
Interventions: Biological: KW-0761 KW-0761 is administered weekly for 8 weeks as an intravenous infusion of 2 hours at
Completed Study Name: Lenalidomide in HTLV-1 Adult T-Cell Leukemia
Condition: Adult T Cell Leukemia/Lymphoma
Date: 2011-01-10
Interventions: Drug: Lenalidomide 25mg or 10mg (based on creatinine clearance) once daily for days 1-21 of a 28 day cyc
Active, not recruiting Study Name: A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
Condition: Adult T-Cell Leukemia-Lymphoma
Date: 2012-11-07
Interventions: Drug: Lenalidomide 25 mg of Lenalidomide administered orally once daily
Recruiting Study Name: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Condition:
  • Adult T-cell Leukemia-Lymphoma
  • ATLL

Date: 2016-04-10
Interventions:
  • Drug: Belinostat Belinostat wi
Completed Study Name: A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma
Condition:
  • Adult T-cell Leukemia-Lymphoma
  • Peripheral T-cell Lymphoma

    • Date: 2010-07-22
    Interventions: Drug: Lenalidomide Lenalidomide: 25mg daily on day 1-21 of each 28days cycle (1st cohort), 25 mg daily o
Completed Study Name: A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
Condition:
  • Adult T-cell Leukemia
  • Lymphoma

Date: 2005-09-01
Interventions:
  • Drug: VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis
Completed Study Name: A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Condition:
  • Adult T Cell Leukemia
  • Adult T Cell Lymphoma

Date: 2011-05-12
Interventions:
  • Drug: IMTOX-25 This agent is s
Next >>>